We develop treatment methods with unique properties in the therapeutic fields of migraine and pain related to cancer.
Download the Company Description.
Klaria Pharma Holding AB (publ) announces that the company has finalized and signed the agreement for the grant of 21 MSEK in total from the EU Horizon 2020...
We are using cookies to optimize your browsing experience. By continuing your browsing you consent to such use.